USFDA successfully completes inspection at Alkem Laboratories’ Taloja facility

12 Aug 2016 Evaluate

Alkem Laboratories has been issued ‘no 483s’ by the United States Food and Drug Administration (USFDA) for it Taloja facility. The USFDA has inspected the company’s Bioequivalence Facility at Taloja in state of Maharashtra from August 01 to August 10, 2016. At the end of the inspection, there were no 483s issued by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.



Alkem Laboratories Share Price

5535.00 -28.80 (-0.52%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×